Performance characteristics of ThyroSeq, ThyGeNEXT/ThyraMIR, and Afirma molecular platforms in evaluation of 1252 cytologically-indeterminate thyroid nodules

Connelly, C. F., Smithgall, M. C., Desai, N., Cimic, A., & Baskota, S. U. (2025). Performance characteristics of ThyroSeq, ThyGeNEXT/ThyraMIR, and Afirma molecular platforms in evaluation of 1252 cytologically-indeterminate thyroid nodules. Journal of the American Society of Cytopathology. https://doi.org/10.1016/j.jasc.2025.04.003
Authors:
Courtney F Connelly
Marie C Smithgall
Niyati Desai
Adela Cimic
Swikrity U Baskota
Affiliated Authors:
Courtney F Connelly
Marie C Smithgall
Niyati Desai
Adela Cimic
Columbia Affiliation:
Author Keywords:
indeterminate thyroid nodule
molecular testing
thyroid
thyroid cytopathology
thyroid nodule
elink
Publication Type:
Article
Unique ID:
10.1016/j.jasc.2025.04.003
PMID:
40382304
DOI:
10.1016/j.jasc.2025.04.003
Journal:
Journal of the American Society of Cytopathology
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record

Record Created: